Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by Supermariogon Jan 19, 2018 5:12pm
181 Views
Post# 27397908

RE:RE:RE:CMED will get either $61.44 or $93.80 per share from ACB

RE:RE:RE:CMED will get either $61.44 or $93.80 per share from ACBWWooWW, would your initials be BZ ?

MartialArts wrote: That capped offer was rejected by CMED management and there is no chances 66.6% of CMED shareholders will accept a $10 discount off their shares.  That ship has sailed and yes, it would have been the "coup" of 2017 for ACB but they missed it.  Please research and it's clear as day.

Fortunately, ACB is coming back to the table with a better offer and I expect the original 4.53 ACB shares for 1 CMED share ratio to be the starting point of discussions.  And this won't be a hostile take over, it will be a friendly merger.  CMED divisoin will agree to continue to focus on the medical side, extraction, etc and ACB division will agree to continue to the acquisition, promotion etc.

ACB is correct in saying this will be a good match up.

ACB and the insiders won't want to carry this into the court system, that's completely against their mode of operation.

As for the deal, it's getting redone this weekend. Look at the the Globe and Mail and The Financial Post are saying just today:

2018-01-19 07:31 ACB Aurora Cannabis Inc 12.97 In the News FP says CanniMed to hold talks with Aurora Cannabis
2018-01-19 06:44 ACB Aurora Cannabis Inc 12.97 In the News Globe says Aurora to sweeten offer for CanniMed

You need to remember that Cannimed is the longest producer of MMJ out there. They produce some of the best oils which will be what people use once this becomes legal. 

CMED just resisted getting into the recreational marijuana space but they have recently realized the markets will continue to punish and undervalue them.  That's why they seeked out a recreational marijuana partner.

Bottom line CMED has a market cap of just $850M.  Compare that with ACB at $6.10B and its easy to see that Cannimed is the #1 value play out there, with 3-4 times the clients that Aurora has and with well known and well respected CanniMed Oils.




<< Previous
Bullboard Posts
Next >>